Impact of certified CME in atrial fibrillation on administrative claims

Stephanie A Stowell1, Allison J Gardner, Joseph S Alpert

  • 1Med-IQ, Baltimore, MD 21223, USA. sstowell@med-iq.com

Insights

Continuing medical education (CME) on atrial fibrillation (AF) reduced healthcare costs and utilization. Administrative claims data effectively measured physician practice changes and patient outcomes following AF CME.

Area of Science:

  • Medical Education Research
  • Health Services Research
  • Cardiology

Background:

  • Continuing Medical Education (CME) aims to improve physician practice and patient outcomes.
  • Measuring the impact of CME on physician behavior and clinical outcomes can be challenging.
  • Atrial fibrillation (AF) management requires adherence to evidence-based guidelines.

Purpose of the Study:

  • To assess if administrative claims databases can measure physician behavior changes after an AF-focused CME activity.
  • To evaluate the impact of AF CME on healthcare utilization and costs for AF patients.

Main Methods:

  • Retrospective analysis of administrative claims data from Humana health system physicians.
  • Comparison of physician treatment patterns and AF patient outcomes 6 months before and after CME participation.
  • Assessment of physician knowledge gains related to AF management.

Main Results:

  • Physician participation in AF CME was associated with significant reductions in AF-related healthcare costs and utilization.
  • A decrease in the length of hospital stay for AF patients was observed post-CME.
  • Physicians demonstrated significant knowledge improvement in evidence-based AF care strategies.

Conclusions:

  • Administrative claims data offer an innovative and potentially valid method for evaluating CME effectiveness.
  • CME activities can influence physician practice, leading to improved patient outcomes and reduced healthcare costs.
  • Further research is warranted to explore drivers of change and the utility of claims data in measuring CME impact.
Abstract

Related Concept Videos

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...